FDA Approvals - Lupin Receives US FDA Approval for Novel Formulation of Suprax(R)
Lupin Receives US FDA Approval for Novel Formulation of Suprax(R) Suspension (PR Newswire via Yahoo! Finance)
Lupin Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration has approved the company's application for Suprax . Commercial shipments of the product have commenced.
Boca Pharmacal Receives FDA Approval for Generic Version of Panlor(R)SS (Business Wire via Yahoo! Finance)
CORAL SPRINGS, Fla.----Boca Pharmacal, Inc. made two major announcements today with the U.S. Food and Drug Administration granting its final approval for the Company's Abbreviated New Drug Application to market its generic version of and Panlor SS and the signing of an exclusive marketing and distribution agreement with Tedor Pharma Inc. for Didrex .
Anika Therapeutics Receives CE Mark Approval for its Cosmetic Tissue Augmentation Product ELEVESS(TM) to be Marketed by ... (FinanzNachrichten)
WOBURN, Mass., April 12 /PRNewswire-FirstCall/ -- Anika Therapeutics, ( Nachrichten ) Inc. today announced that it has received CE Mark certification for the commercial sale of its cosmetic dermatology product, ELEVESS(TM), in the European Union.